SCOR Diversity, Equity and Inclusion

Registration is complimentary.

No pre-registration required.

Thursday, July 1, 2021, 12:00 AM - Sunday, June 30, 2024, 12:00 AM

A knowledge activity for Sharp affiliated physicians, nurse practitioners, physician assistance, pharmacists, pharmacy technicians, and other interested health care professionals

1. Define microaggression as related to diversity and cultural competence
2. State why microaggressions are harmful to health care practitioners and patients and families
3. Summarize the importance of equity, diversity and inclusion within a health care organization
4. Access resources related to diversity, equity and inclusion made available by the Sharp Equality Alliance.
5. List the steps to take when making a mistake related to diversity, equity and inclusion.

Accreditation:  Sharp HealthCare is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

CME Credit:  Sharp HealthCare designates this Enduring material activity for a maximum of 0.25 AMA PRA Category 1 Credit(s).  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

PA Credit:  PAs may claim a maximum of 0.25 Category 1 credits for completing this activity. NCCPA accepts AMA PRA Category 1 Credit™ from organizations accredited by ACCME or a recognized state medical society.

NP Credit:  AANPCB accepts AMA PRA Category 1 Credit(s) issued by organizations accredited by ACCME as an equivalent number of hours of participation. 0.25 AMA PRA Category 1 credit = 0.25 contact hour(s).

   

Accreditation:  Sharp HealthCare is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

CPE Credit:  Sharp HealthCare designates this home study for a maximum of 0.25 contact hours (0.25 CEUs).  Partial credit will not be awarded.  Pharmacists can verify their credits at  CPE Monitor within 30 days of completion of this activity.  UAN: 0571-0000-21-017-H04-P and 0571-0000-21-017-H04-T

 

       

Disclosure: As an organization accredited by the ACCME, Sharp HealthCare requires everyone who is in a position to control the content of an education activity to disclose all relevant financial relationships with any commercial interest. The ACCME defines "relevant financial relationships" as financial relationships in any amount, occurring within the past 12 months, including financial relationships of a spouse or life partner, that could create a conflict of interest.  The ACPE defines "relevant financial relationships" as financial relationships in any amount, occurring within the past 12 months.”  Any individual who refuses to disclose relevant financial relationships will be disqualified from being a planning committee member, a teacher, or an author of CME, and cannot have control of, or responsibility for, the development, management, presentation or evaluation of the CME activity.  Sharp HealthCare, encourages faculty to identify investigational products or off-label uses of products regulated by the US Food and Drug Administration, at first mention and where appropriate in the content.

Cultural & Linguistic Competency: This activity is in compliance with California Assembly Bill 1195 which requires that all CME activities comprising a patient care element include curriculum addressing the topic of cultural and linguistic competency.  The intent of this bill is to ensure that health care professionals are able to meet the cultural and linguistic concerns of a diverse patient population through effective and appropriate professional development.  Cultural and linguistic competency was incorporated into the planning of this activity.

Mitigation of Relevant Financial Relationships

Sharp HealthCare adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education (ACE). Any individuals in a position to control the content of an ACE activity, including faculty, planners, reviewers or others are required to disclose all financial relationships with ineligible entities. All relevant conflicts of interest have been mitigated prior to the commencement of the activity.